Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, CA 94143-0320, USA.
J Natl Cancer Inst. 2013 Jul 17;105(14):1043-9. doi: 10.1093/jnci/djt124. Epub 2013 Jun 6.
Benign breast disease and high breast density are prevalent, strong risk factors for breast cancer. Women with both risk factors may be at very high risk.
We included 42818 women participating in the Breast Cancer Surveillance Consortium who had no prior diagnosis of breast cancer and had undergone at least one benign breast biopsy and mammogram; 1359 women developed incident breast cancer in 6.1 years of follow-up (78.1% invasive, 21.9% ductal carcinoma in situ). We calculated hazard ratios (HRs) using Cox regression analysis. The referent group was women with nonproliferative changes and average density. All P values are two-sided.
Benign breast disease and breast density were independently associated with breast cancer. The combination of atypical hyperplasia and very high density was uncommon (0.6% of biopsies) but was associated with the highest risk for breast cancer (HR = 5.34; 95% confidence interval [CI] = 3.52 to 8.09, P < .001). Proliferative disease without atypia (25.6% of biopsies) was associated with elevated risk that varied little across levels of density: average (HR = 1.37; 95% CI = 1.11 to 1.69, P = .003), high (HR = 2.02; 95% CI = 1.68 to 2.44, P < .001), or very high (HR = 2.05; 95% CI = 1.54 to 2.72, P < .001). Low breast density (4.5% of biopsies) was associated with low risk (HRs <1) for all benign pathology diagnoses.
Women with high breast density and proliferative benign breast disease are at very high risk for future breast cancer. Women with low breast density are at low risk, regardless of their benign pathologic diagnosis.
良性乳腺疾病和乳腺密度高是乳腺癌的常见且强烈的危险因素。同时具有这两个危险因素的女性可能面临极高的风险。
我们纳入了 42818 名参加乳腺癌监测联盟的女性,她们在入组前均无乳腺癌诊断,且至少接受过一次良性乳腺活检和乳房 X 光检查;在 6.1 年的随访中,有 1359 名女性发生了乳腺癌(78.1%为浸润性癌,21.9%为导管原位癌)。我们使用 Cox 回归分析计算了风险比(HR)。参考组为非增生性改变和平均密度的女性。所有 P 值均为双侧。
良性乳腺疾病和乳腺密度与乳腺癌独立相关。非典型增生和极高密度的组合并不常见(活检的 0.6%),但与乳腺癌风险最高相关(HR=5.34;95%置信区间[CI]为 3.52 至 8.09,P<.001)。无非典型增生的增生性疾病(活检的 25.6%)与风险升高相关,而这种风险在不同密度水平之间变化不大:平均密度(HR=1.37;95%CI 为 1.11 至 1.69,P=0.003)、高密度(HR=2.02;95%CI 为 1.68 至 2.44,P<.001)或极高密度(HR=2.05;95%CI 为 1.54 至 2.72,P<.001)。低乳腺密度(活检的 4.5%)与所有良性病理诊断相关的低风险(HR<1)相关。
乳腺密度高且患有增生性良性乳腺疾病的女性未来发生乳腺癌的风险非常高。无论良性病理诊断如何,乳腺密度低的女性风险都较低。